中大機構典藏-NCU Institutional Repository-提供博碩士論文、考古題、期刊論文、研究計畫等下載:Item 987654321/61928
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 80990/80990 (100%)
造訪人次 : 41956840      線上人數 : 1526
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋


    請使用永久網址來引用或連結此文件: http://ir.lib.ncu.edu.tw/handle/987654321/61928


    題名: Phosphodiesterase 4B調控輔助T細胞功能對氣喘與類風溼性關節炎之致病作用;Role of Phosphodiesterase 4B in Helper T Cell Functions and the Pathogenesis of Allergic Asthma and Rheumatoid Arthritis
    作者: 金秀蓮
    貢獻者: 國立中央大學生命科學系
    關鍵詞: 基礎醫學;生物技術(醫)
    日期: 2014-03-10
    上傳時間: 2014-03-11 09:47:54 (UTC+8)
    出版者: 行政院國家科學委員會
    摘要: 研究期間:10308~10407;Both asthma and rheumatoid arthritis (RA) are chronic inflammatory diseases, each affecting at least 0.5% population worldwide. Allergic asthma is considered a Th2 cytokine-driven disease, characterized by chronic airway inflammation, airway hyperresponsiveness (AHR), mucosal edema, and airway obstruction. RA is an autoimmune disorder, characterized by synovial inflammation and destruction of joint cartilage and bone, and is thought to be mediated by persistent synthesis of proinflammatory cytokines and matrix metalloproteinases (MMP) in macrophages, Th1 and/or Th17 cells, and synovial tissue cells. Although the modulatory effects of cAMP signaling in inflammatory cells have been widely explored, the exact physiological functions of this regulatory pathway in these two diseases remain to be defined. Here we will test the hypothesis that a gene (PDE4B) coding for the family cAMP-specific phosphodiesterases (PDE4s), enzymes that degrade and inactivate the second messenger cAMP, plays a critical role in modulating inflammatory responses, and hence the clinical symptoms in these two diseases. Of the four PDE4 genes present in mammals (PDE4A, 4B, 4C, and 4D), three (4A, 4B, and 4D) are expressed in inflammatory cells. Although ablation of each of these genes protects against AHR, only ablation of PDE4B causes marked disruption in airway inflammation and Th2 cytokine production. The expression of PDE4B in macrophages is up-regulated by activation of Toll-like receptor signaling, and TNF- production to LPS is greatly reduced in PDE4B-null mice but not in PDE4A- or PDE4D-null mice. Preliminary results also showed that PDE4B null mice are more resistant to collagen-induced arthritis (CIA) compared with the wild-type mice. On the basis of these preliminary findings, we propose to use these knockout models to further understand how ablation of PDE4B, and thereby disruption of cAMP signaling impacts inflammatory responses and AHR in a model of allergic asthma as well as joint destruction in a CIA model. Experiments are organized along four main specific aims carried out in three years. With the first Specific Aim, we propose to further determine the cellular basis of the reduced airway responses in PDE4B null mice using the adoptive transfer strategy. Experiments described in the second Specific Aim will define the molecular mechanisms that underlie the effects of PDE4B on Th2 cell functions by determining PDE4 expression pattern during Th2 cell differentiation as well as assessing the effects of TNF- and IL-10 in PDE4 null mice. The third Specific Aim is to test the newly developed PDE4B-selective inhibitor Compound 33 in vitro and in vivo to determine whether the acute pharmacological effects resemble the findings observed in PDE4B null mice. The fourth Specific Aim will be devoted to defining the role of individual PDE4 subtypes in the pathogenesis of RA using a CIA model. The effect of PDE4s on Th1/Th17 differentiation and their cytokine production will be assessed. These studies will provide new insights into the role of PDE4B in the Th cell functions associated with the pathogenesis of allergic asthma and RA. Given the established potential of nonselective PDE4 inhibitors as non steroidal anti-inflammatory drugs, a better understanding of the function of PDE4s, in particular of PDE4B, in these inflammatory diseases will open new opportunities for PDE4 drug design.
    關聯: 財團法人國家實驗研究院科技政策研究與資訊中心
    顯示於類別:[生命科學系] 研究計畫

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML469檢視/開啟


    在NCUIR中所有的資料項目都受到原著作權保護.

    社群 sharing

    ::: Copyright National Central University. | 國立中央大學圖書館版權所有 | 收藏本站 | 設為首頁 | 最佳瀏覽畫面: 1024*768 | 建站日期:8-24-2009 :::
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 隱私權政策聲明